Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to Botox and similar injections.
These treatments, leveraging botulinum toxins to target specific muscles and erase wrinkles, currently carry a 'black box' warning about the potential for the intended effects to spread to other areas.
The petition targets six toxin-based injections, including AbbVie Inc's (NYSE: ABBV) Botox, Revance Therapeutics Inc's (NASDAQ: Full story available on Benzinga.com